Foclivia Sospensione iniettabile in una siringa Preriempita

国家: 瑞士

语言: 意大利文

来源: Swissmedic (Swiss Agency for Therapeutic Products)

现在购买

资料单张 资料单张 (PIL)
01-05-2024
产品特点 产品特点 (SPC)
01-05-2024

有效成分:

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

可用日期:

Medius AG

ATC代码:

J07BB02

INN(国际名称):

haemagglutininum influenzae A (H5N1), neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14)

药物剂型:

Sospensione iniettabile in una siringa Preriempita

组成:

haemagglutininum influenzae A (H5N1) et neuraminidasum inactivatum (Virus-Stamm A/Vietnam/1194/2004 NIBRG-14) 7.5 µg, adjuvans MF59C.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.

类:

B

治疗组:

Vaccini

治疗领域:

Pandemico Influenzale Vaccino

授权状态:

zugelassen

授权日期:

2018-04-20

其他语言的文件

产品特点 产品特点 德文 25-10-2018
资料单张 资料单张 法文 01-05-2024
产品特点 产品特点 法文 01-02-2020